| Literature DB >> 29277910 |
Lionel Faivre1, Chloé Couzin1, Hélène Boucher1,2, Thomas Domet1, André Desproges1, Olivier Sibony1,3, Marina Bechard4, Valérie Vanneaux1,5, Jérôme Larghero1,3,5, Audrey Cras1,2,6.
Abstract
After 30 years of hematopoietic stem cell use for various indications, umbilical cord blood is considered as an established source of cells with marrow and postmobilization peripheral blood. The limited number of cells still remains a problematic element restricting their use, especially in adults who require to be grafted with a higher cell number. Improving the quality of harvested cord blood, at least in terms of volume and amount of cells, is essential to decrease the number of discarded units. In this review, we examine several variables related to parturient, pregnancy, labor, delivery, collection, the newborn, umbilical cord, and placenta. We aim to understand the biologic mechanisms that can impact cord blood quality. This knowledge will ultimately allow targeting donors, which could provide a rich graft and improve the efficiency of the collection.Entities:
Mesh:
Year: 2017 PMID: 29277910 DOI: 10.1111/trf.14447
Source DB: PubMed Journal: Transfusion ISSN: 0041-1132 Impact factor: 3.157